4C Biomed Overview
4C Biomed combines cutting-edge science, real-world clinical insights and unique autologous cell systems (i.e. cancer and immune cells from the same patient) to drive the development of immuno-oncology therapies. Its lead drug is in a stage of IND-enabling studies and is planned to enter clinical Phase I in 2025. 4C Biomed’s technology leverages a uniquely sensitive, immunological-based screening platform, which not only identifies novel immuno-oncology targets but also promises to accelerate the journey from discovery to clinical application.
Latest News
No news articles.
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | Undisclosed |
| Last funding | Undisclosed |
| Stage | Seed |
| Rounds | 1 |
| Investors | 1 |
Team Members
3
Employees: 1-10
Web & Social Links
| Website | 4cbiomed.com/ |
Locations
Ha-Melakha St 5, Netanya, Israel
London, UK
Photos & Videos
No files yet
4C Biomed Business
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentTarget Customer
Healthcare & Life SciencesLife SciencesPharmaceuticalsCore Technology
BiologicalsTags (8)
cancer-therapyoncologyimmunotherapyimmunologydrug-discoverycancerdrug-developmentpharmaceuticals4C Biomed Financials
4C Biomed Lifecycle
4C Biomed News
0 articlesNo news articles.
4C Biomed Team
Employee Info
| Employees (range) | 1-10 |
| Exact count | 10 |
| Team members | 3 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 7 classification IDs that could be used for matching.
4C Biomed Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 80/100 |
| Missing | sector, video or image, news, markets, not claimed |
| BI Verification | Yanina Wainscheinker |
| Registrar ID | 515406163 |
| Creator | Yanina Wainscheinker |
| Creator email | yanina.wainscheinker@sncentral.org |
| Last update | 2024-10-23T00:00:00.000Z |
| Created | 2024-10-23T00:00:00.000Z |